MD HB920 | 2019 | Regular Session


Spectrum: Moderate Partisan Bill (Republican 12-3)
Status: Introduced on February 8 2019 - 25% progression, died in chamber
Action: 2019-04-05 - Unfavorable Report by Health and Government Operations; Withdrawn
Text: Latest bill text (Introduced) [PDF]


Requiring the Secretary of Health, by a certain date each year, to identify a certain number of certain prescription drugs on which the State spends a certain amount of money; requiring the Secretary to require a certain pharmaceutical manufacturer to report certain cost changes and expenditures during a certain period of time; requiring the Secretary, by a certain date each year, to publish a report on the Maryland Department of Health's website based on the information the Secretary receives under certain provisions of the Act; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.


Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting



2019-04-05HouseUnfavorable Report by Health and Government Operations; Withdrawn
2019-02-13HouseHearing 3/06 at 1:00 p.m.
2019-02-08HouseFirst Reading Health and Government Operations


Maryland State Sources

Bill Comments